| 标题 |
[求助补充材料]
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:David Fiorentino; Aaron R. Mangold; Victoria P. Werth; Lisa Christopher‐Stine; Alisa N. Femia; et al 出版日期:2025-01-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)